MetLife, Inc. $MET Shares Purchased by Foster & Motley Inc.

Key Points

• Foster & Motley Inc. increased its stake in MetLife, Inc. by 12.4% during the 2nd quarter, now holding 72,593 shares valued at $5.8 million.
• MetLife reported earnings per share of $2.02 for the last quarter, falling short of the expected $2.32, with revenues also below estimates at $17.34 billion.
• The company announced a quarterly dividend of $0.5675 per share, representing an annualized yield of 2.9%, which will be paid on December 9th.

Foster & Motley Inc. lifted its position in MetLife, Inc. (NYSE:MET - Free Report) by 12.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,593 shares of the financial services provider's stock after purchasing an additional 7,985 shares during the period. Foster & Motley Inc.'s holdings in MetLife were worth $5,838,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Kathmere Capital Management LLC raised its position in MetLife by 88.2% during the second quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider's stock worth $509,000 after acquiring an additional 2,965 shares during the period. First Horizon Advisors Inc. raised its position in shares of MetLife by 4.8% in the first quarter. First Horizon Advisors Inc. now owns 422,684 shares of the financial services provider's stock valued at $33,937,000 after buying an additional 19,192 shares during the last quarter. Pinnacle Financial Partners Inc acquired a new stake in shares of MetLife in the first quarter valued at about $255,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of MetLife by 20.7% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider's stock valued at $4,735,000 after buying an additional 10,414 shares during the last quarter. Finally, Heartland Bank & Trust Co acquired a new stake in shares of MetLife in the first quarter valued at about $516,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Up 0.9%

Shares of MET opened at $78.55 on Friday. The stock has a market capitalization of $52.24 billion, a PE ratio of 13.31, a P/E/G ratio of 0.70 and a beta of 0.86. MetLife, Inc. has a 1 year low of $65.21 and a 1 year high of $89.05. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. The company's 50-day simple moving average is $80.20 and its 200-day simple moving average is $78.11.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing the consensus estimate of $2.32 by ($0.30). The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The firm's revenue was down 2.7% compared to the same quarter last year. During the same period last year, the business earned $2.28 EPS. Analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be given a dividend of $0.5675 per share. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. MetLife's dividend payout ratio (DPR) is 38.47%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on MET shares. Morgan Stanley increased their target price on shares of MetLife from $94.00 to $97.00 and gave the company an "overweight" rating in a research report on Tuesday, October 7th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a report on Monday, August 11th. JPMorgan Chase & Co. upped their price objective on shares of MetLife from $86.00 to $95.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Piper Sandler lowered shares of MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price objective for the company. in a report on Friday, September 19th. Finally, Wolfe Research raised shares of MetLife to a "strong-buy" rating in a report on Tuesday, September 16th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, MetLife has a consensus rating of "Moderate Buy" and an average price target of $95.18.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.